Combating the threat of biowarfare and bioterrorism: Defending against biological weapons is critical to global security

BioScience

Volumn 49, Issue 6, 1999, Pages 465-477

  Atlas, Ronald M ^a  

^a UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0032908208     PISSN: 00063568     EISSN: None     Source Type: Journal    
DOI: 10.2307/1313554     Document Type: Article

References (28)

1. Alibek K. 1998. Terrorist and Intelligence Operations: Potential Impact on the US Economy. Statement before the Joint Economic Committee, US Congress, May 20, 1998. (2 February 1999).
2. Atlas RM. 1998a. Biological weapons pose challenge for microbiology community: Microbiologists should help shape policies protecting against biological weapons but safeguarding legitimate research. ASM News 64: 383-389.
3. _. 1998b. The medical threat of biological weapons. Critical Reviews in Microbiology 24: 157-168.
4. Barton R. 1998. The application of the UNSCOM experience to international biological arms control. Critical Reviews in Microbiology 24: 219-234.
5. Carus WS. 1998a. Biological warfare threats in perspective. Critical Reviews in Microbiology 24: 149-156.
6. _. 1998b. Bioterrorism and Biocrimes: The Illicit Use of Biological Agents in the 20th Century. Washington (DC): Center for Counterproliferation Research, National Defense University.
7. Cheng J, Fortina P, Surrey S, Kricka LJ, Wilding P. 1996. Microchip-based devises for molecular diagnosis of genetic diseases. Molecular Diagnosis 1: 183-200
8. Christopher G, Cieslak TJ, Pavlin JA, Eitzen EM. 1997. Biological warfare: A historical perspective. Journal of the American Medical Association 278: 412-417.
9. Danzig R, Berkowsky PB. 1997. Why should we be concerned about biological warfare? Journal of the American Medical Association 278: 431-432.
10. Derbes VJ. 1966. De Musis and the great plague of 1348: A forgotten episode of bacteriological war. Journal of the American Medical Association 196: 59-62.
11. Ferguson JR. 1997. Biological weapons and US law. Journal of the American Medical Association 278: 357-360.
12. Franz DR, Jahrling PD, Friedlander AM, McClain DJ, Hoover DL, Bryne WR, Pavlin JA, Christopher GW, Eitzen EM Jr. 1997. Clinical recognition and management of patients exposed to biological warfare agents. Journal of the American Medical Association 278: 399-411.
13. Harris SH. 1994. Factories of Death. New York: Routledge.
14. Henderson DA. 1998. Bioterrorism as a health threat. Emerging Infectious Diseases 4: 488-492.
15. Hugh-Jones M. 1992. Wickham Steed and German biological warfare research. Intelligence and National Security 7: 379-402.
16. International Scientific Commission for the Investigation of the Facts Concerning Bacterial Warfare in Korea and China. 1952. Report. Peking: International Scientific Commission for the Investigation of the Facts Concerning Bacterial Warfare in Korea and China.
17. Kadlec RP, Zelicoff AP, Vrtis AM. 1997. Biological weapons control: Prospects and implications for the future. Journal of the American Medical Association 278: 351-356.
18. Lederberg J. 1997. Infectious disease and biological weapons: Prophylaxis and mitigation. Journal of the American Medical Association 278: 435-436.
19. Leitenberg M. 1994. The conversion of biological warfare research and development facilities to peaceful uses. Pages 77-105 in Geissler D, Woodall JP, eds. Control of Dual Threat Agents: The Vaccines for Peace Program. New York: Stockholm International Peace Research Institute and Oxford University Press.
20. _. 1997. Conversion of biological weapon research and development: A global view in 1997. Paper presented at First Forum on Possible Consequences of the Misuse of Biological Sciences; 3-6 December 1997; Como, Italy.
21. Meselson MJ, Guillemin M, Hugh-Jones A, Langmuir I, Popova A, Shelokov A, Yampolskaya O. 1994. The Sverdlovsk anthrax outbreak of 1979. Science 266: 1202-1208.
22. [NAS] National Academy of Sciences. 1997. Controlling Dangerous Pathogens: A Blueprint for US-Russian Cooperation. Washington (DC): National Academy of Sciences.
23. Parkman F. 1901. The Conspiracy of Pontiac and the Indian War After the Conquest of Canada. Boston: Little, Brown & Co.
24. Roberts B. 1998. Export controls and biological weapons: New roles, new challenges. Critical Reviews in Microbiology 24: 235-254.
25. Robertson AG, Robertson LJ. 1995. From asps to allegations: Biological warfare in history. Military Medicine 160: 369-373.
26. Russell PK. 1997. Biologic terrorism: Responding to the threat. Emerging Infectious Diseases 3: 203-204.
27. Simon JD. 1997. Biological terrorism: Preparing to meet the threat. Journal of the American Medical Association 278: 428-430.
28. Stephenson J. 1997. Pentagon-funded research takes aim at agents of biological warfare. Journal of the American Medical Association 278: 373-375.